Wendy Hill is an experienced clinical operations and program management professional. They served as Executive Director and Head of Clinical Operations at Sunesis Pharmaceuticals from 2013 to 2017, and held leadership roles at notable companies including Genocea Biosciences, where they led the development of a personalized cancer vaccine from 2017 to 2019, and Codiak BioSciences as Vice President of Clinical Operations from 2019 to 2021. Currently, Wendy is the Vice President of Clinical Operations at Merus N.V. and possesses both a Bachelor of Science in Biotech Engineering and an MBA from Dublin City University.
This person is not in any teams
This person is not in any offices